ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,339, issued on Nov. 3, was assigned to THE UNIVERSITY OF TULSA (Tulsa, Okla.).
"Synthesis and use of N-benzyl sulfonamides" was invented by Angus A Lamar (Tulsa, Okla.) and Robert J Sheaff (Owasso, Okla.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a method for preparing N-benzyl sulfonamides. Also disclosed is a composition for treating cancer. The composition includes a N-benzyl sulfonamide and a metabolic inhibitor. Also disclosed is a method for determining the impact on cell ATP levels of a composition containing a N-benzyl sulfonamide with or without a metabolic inhibitor."
The patent was filed on July 23, 2021, under Applicatio...